Tag: Hutchinson-Gilford

Clinical TrialsPharmaceuticals

Progeria

The first drug to treat Hutchinson-Gilford Progeria, a rare and uniformly fatal rapid aging disease, has been approved by the FDA. It can prolong the life of these children by 2.5 years, but it is very expensive.

/ December 8, 2020